Financhill
Sell
33

CARM Quote, Financials, Valuation and Earnings

Last price:
$0.45
Seasonality move :
-13.78%
Day range:
$0.39 - $0.41
52-week range:
$0.14 - $1.38
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.83x
P/B ratio:
123.48x
Volume:
573.5K
Avg. volume:
28.8M
1-year change:
-66.67%
Market cap:
$16.7M
Revenue:
$19.6M
EPS (TTM):
-$1.22

Earnings Data

Next earnings date for CARM
Aug 08
2025
Most recent earnings per share
-$0.22
Missed by $0.10
(May 13/2025)
Consensus Estimate
-$0.12
(May 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CARM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 $3.8M -- -- -$0.10 --
08/08/2025 Q2 $3.8M -- -- -$0.09 --
05/13/2025 Q1 $1.9M $3.7M -$0.22 -$0.12 -$0.10
12/31/2024 Q4 $5.4M $3.7M -$0.42 -$0.16 -$0.26
11/07/2024 Q3 $5M $3.4M -$0.31 -$0.36 $0.05
08/08/2024 Q2 $3.9M $9.2M -$0.27 -$0.36 $0.09
05/10/2024 Q1 $4.4M $3.4M -$0.46 -$0.39 -$0.07
02/29/2024 Q4 $2.9M $4.3M -$0.48 -$0.54 $0.06
11/09/2023 Q3 $890K $3.8M -$0.53 -$0.52 -$0.01
08/10/2023 Q2 $3.2M $3.6M -$0.49 -$0.60 $0.11
05/11/2023 Q1 -- $3.2M -$1.93 -- --
12/31/2022 Q4 -- $3.7M -$0.42 -- --
09/30/2022 Q3 -- $2.6M -$0.46 -- --
06/30/2022 Q2 -- $2.7M -$0.37 -- --
03/31/2022 Q1 -- $822K -$0.28 -- --

CARISMA Therapeutics Earnings Questions

  • How Much did CARISMA Therapeutics Generate in Revenue Last Quarter?

    CARISMA Therapeutics reported $3.7M worth of top line sales in its most recent quarter.

  • Did CARISMA Therapeutics Beat Earnings Last Quarter?

    CARISMA Therapeutics announced earnings per share of -$0.22 which represents a miss of analyst forecast a -$0.12 per share.

  • Is CARISMA Therapeutics Profitable?

    CARISMA Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for CARISMA Therapeutics EPS Next Year?

    CARISMA Therapeutics's earnings are forecast to decrease from -$1.46 per share to -$1.20 per share next year representing a decrease of -71.92%.

  • When is CARISMA Therapeutics's Earnings Date?

    CARISMA Therapeutics's next earnings date is August 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Oklo Stock Double?
Will Oklo Stock Double?

Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…

Why a $5 Stock Is Suddenly a Cash Machine
Why a $5 Stock Is Suddenly a Cash Machine

If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…

Is Roku Stock Undervalued Now?
Is Roku Stock Undervalued Now?

At roughly $89 a share, Roku (NASDAQ: ROKU) trades for barely…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 14

MiNK Therapeutics [INKT] is down 36.03% over the past day.

Buy
51
NEGG alert for Jul 14

Newegg Commerce [NEGG] is down 26.42% over the past day.

Buy
68
ATRO alert for Jul 14

Astronics [ATRO] is down 1.02% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock